Bayesian Capital Management’s MannKind Corp MNKD Stock Holding History

Bayesian Capital Management’s Portfolio MNKD Stock Details MNKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,200	Closed	-$200K	–	196
2025 Q4	$200K	Buy	+35,200	New	+$194K	0.46%	91
2024 Q2	–	Sell	-56,809	Closed	-$257K	–	959
2024 Q1	$257K	Sell	56,809 -1,300	-2%	-$5.11K	0.02%	600
2023 Q4	$212K	Buy	58,109 +25,309	+77%	+$96.7K	0.02%	587
2023 Q3	$135K	Buy	+32,800	New	+$147K	0.02%	584
2022 Q4	–	Sell	-117,300	Closed	-$362K	–	937
2022 Q3	$362K	Buy	117,300 +54,200	+86%	+$204K	0.07%	360
2022 Q2	$240K	Buy	+63,100	New	+$232K	0.04%	560
2017 Q1	–	Sell	-9,700	Closed	-$31K	–	599
2016 Q4	$31K	Buy	+9,700	New	+$28K	0.01%	574

Other funds holding MNKD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Bayesian Capital Management's MNKD Position: Q1 2026 in Review

Bayesian Capital Management sold out of MannKind Corp (MNKD) in Q1 2026, closing a stake of 35,200 shares — an estimated $200K sold.

Bayesian Capital Management first reported a position in MNKD in Q4 2016 and held it in 7 quarters. The position peaked at $362K in Q3 2022. 250 funds tracked by Wall St. Rank hold MNKD as of Q1 2026.

Bayesian Capital Management reported no remaining MannKind Corp position as of Q1 2026 after selling out during the quarter.
Bayesian Capital Management sold 35,200 MannKind Corp shares in Q1 2026, an estimated $200K.
Bayesian Capital Management first reported a position in MannKind Corp in Q4 2016 and held it in 7 quarters.
Bayesian Capital Management's MannKind Corp position peaked at $362K in Q3 2022.
250 funds tracked by Wall St. Rank held MannKind Corp as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.